COLL vs KEY
Collegium Pharmaceutical Inc (COLL) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the COLL and KEY stock pages for the full models.
Not investment advice.